CryptoWeeklies / Reports / INJ
Injective (INJ) research
Every model we publish for Injective — valuation, risk and forecast — regenerated daily from market data. Free, no account.
Injective key levels today
The headline figure from each of Injective's reports, as published today. Each comes from the report linked beside it.
| Lifetime TWAP | $11 | TWAP / Gravity Risk |
| Gravity Risk (0-100) | 11.5 | TWAP / Gravity Risk |
| 200-week moving average | $13.56 | 200-Week Moving Average Risk |
| Regression floor | $2.36 | DCA & Regression Fair Value |
| Regression fair value | $6.15 | DCA & Regression Fair Value |
| Regression ceiling | $18.77 | DCA & Regression Fair Value |
| Moving-average risk score | 64.6% | 200-Week Moving Average Risk |
| 20-week SMA risk level (0-1) | 0.48 | 20-Week SMA Risk |
| Log regression deviation | +33.05% | Log Regression Fair Value |
| Forecast base target | $9.50 (68% range $3.05 to $25.11) | Price Forecast |
Is Injective overvalued right now?
Injective trades 26% below its lifetime Time-Weighted Average Price (TWAP), with a Gravity Risk score of 11.5/100.
Where is Injective against its 200-week moving average?
Injective is 39.3% below its 200-week moving average of $13.56, at $8.22. Macro risk score 64.6%.
What is Injective's 20-week moving-average risk level?
Injective at $8.08 sits at risk level 0.48 on a 0-1 scale against its 20-week moving average.
Where is Injective against its DCA fair value?
Injective sits 32% above its regression fair value of $6.15.
Is Injective above or below its log regression fair value?
Injective is 33% above its log regression fair value.
Is Injective in accumulation or euphoria on the rainbow chart?
Injective is in bull phase expansion at $8.01.
What does the model forecast for the Injective price?
Injective model base target $9.50, with a 68% range of $3.05 to $25.11.
Injective against other assets
How does Injective's reading today compare with its own history?
Across 69 weekly readings from 2024-07-14 to 2026-11-09, Injective's premium to its lifetime TWAP ranged from 52% below to 183% above, with a median of 15% above. Today it is 26% below. Against its regression fair value it ranged from 78% below to 452% above over 122 weeks from 2024-06-09 to 2026-11-09, with a median of 97% above; today it is 32% above.
How does Injective's Gravity Risk compare with other crypto assets?
Injective's Gravity Risk of 11.5 is the 17th highest of the 84 crypto assets we track, against a median of 2.0. The lowest reading today, 0, is shared by Cosmos, Axie Infinity, Flow, Flare, Ampleforth, Loopring, Mantra, Ronin and Theta Network, and the highest is Tron at 57.1. By premium to its lifetime TWAP, 26% below, it is the 20th highest of the 84, against a median of 75% below.
Injective's track record
Every weekly DCA reading published for Injective since mid-2024, set beside the price 13 and 26 weeks later: see the receipts.